ÁLVARO PRADA IÑURRATEGUI-rekin lankidetzan egindako argitalpenak (11)

2023

  1. Early biochemical analysis of COVID-19 patients helps severity prediction

    PLoS ONE, Vol. 18, Núm. 5 May

  2. Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

    Frontiers in Aging, Vol. 4

2021

  1. O group is a protective factor for COVID19 in Basque population

    PLoS ONE, Vol. 16, Núm. 4 April

2020

  1. Whole-transcriptome analysis in peripheral blood mononuclear cells from patients with lipid-specific oligoclonal igm band characterization reveals two circular RNAs and two linear rnas as biomarkers of highly active disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-16

2019

  1. ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 5, Núm. 4

2018

  1. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

2015

  1. Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis

    BMC Genomics, Vol. 16, Núm. 1

2014

  1. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis

    Biomarkers in Medicine, Vol. 8, Núm. 5, pp. 653-661

  2. Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. HLA-DRB1*15:01 and multiple sclerosis: A female association?

    Multiple Sclerosis Journal, Vol. 18, Núm. 5, pp. 569-577

  2. TACI mutation in Good's Syndrome: In search of a genetic basis

    Clinical Immunology